Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: Long-term results of the UNICANCER ACCORD 16 phase II trial

Antonin Levy, David Azria, Jean Pierre Pignon, Anne Delarochefordiere, Isabelle Martel-Lafay, Emmanuel Rio, David Malka, Thierry Conroy, Laurent Miglianico, Yves Becouarn, Katty Malekzadeh, Julie Leclercq, Beata Juzyna, Patrick Ezra, Claire Lemanski, Eric Deutsch

Research output: Contribution to journalLetterpeer-review

31 Scopus citations
Original languageEnglish
Pages (from-to)415-416
Number of pages2
JournalRadiotherapy and Oncology
Issue number3
StatePublished - 1 Mar 2015
Externally publishedYes

Bibliographical note

Funding Information:
This study was funded by a medical Grant from Merck KGaA . Merck KGaA have reviewed this manuscript but the views and opinions described do not necessarily reflect those of Merck KGaA.

Cite this